FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Johan Wejde

Research Profile

Anatomy

Tumor Cells, Cultured

Chemicals & Drugs

Physiology

Disorders

Phenomena

Procedures

Concepts & Ideas

Molecular Sequence Data

Co-author Network

Publications

TOP 3
Elsa Arbajian; Otte Brosjö; Andrew L Folpe; Linda Magnusson; Karolin H Nord; Johan Wejde; Fredrik Mertens
A benign vascular tumor with a new fusion gene: EWSR1-NFATC1 in hemangioma of the bone.
Karolin H Nord; Kajsa Paulsson; Srinivas Veerla; Johan Wejde; Otte Brosjö; Nils Mandahl; Fredrik Mertens
Retained heterodisomy is associated with high gene expression in hyperhaploid inflammatory leiomyosarcoma.
Wessen Maruwge; Pádraig D'Arcy; Annika Folin; Slavica Brnjic; Johan Wejde; Anthony Davis; Fredrik Erlandsson; Jonas Bergh; Bertha Brodin
Sorafenib inhibits tumor growth and vascularization of rhabdomyosarcoma cells by blocking IGF-1R-mediated signaling.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Johan Wejde (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Elsa Arbajian; Otte Brosjö; Andrew L Folpe; Linda Magnusson; Karolin H Nord; Johan Wejde; Fredrik Mertens
A benign vascular tumor with a new fusion gene: EWSR1-NFATC1 in hemangioma of the bone.
The American journal of surgical pathology 2013;37(4):613-6.
2012: Karolin H Nord; Kajsa Paulsson; Srinivas Veerla; Johan Wejde; Otte Brosjö; Nils Mandahl; Fredrik Mertens
Retained heterodisomy is associated with high gene expression in hyperhaploid inflammatory leiomyosarcoma.
Neoplasia (New York, N.Y.) 2012;14(9):807-12.
2008: Wessen Maruwge; Pádraig D'Arcy; Annika Folin; Slavica Brnjic; Johan Wejde; Anthony Davis; Fredrik Erlandsson; Jonas Bergh; Bertha Brodin
Sorafenib inhibits tumor growth and vascularization of rhabdomyosarcoma cells by blocking IGF-1R-mediated signaling.
OncoTargets and therapy 2008;1():67-78.
2005: Jan Ahlén; Johan Wejde; Otte Brosjö; Anette Von Rosen; Wen-Hui Weng; Leonard Girnita; Olle Larsson; Catharina Larsson
Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(1):206-16.
2005: Wen-Hui Weng; Mikael Lerner; Dan Grandér; Jan Ahlén; Andrea Villablanca; See-Tong Pang; Johan Wejde; Weng-Onn Lui; Catharina Larsson
Loss of chromosome 13q is a frequently acquired event in genetic progression of soft tissue sarcomas in the abdominal cavity.
International journal of oncology 2005;26(1):5-16.
2004: Ioannis Panagopoulos; Clelia Tiziana Storlazzi; Christopher D M Fletcher; Jonathan A Fletcher; Antonio Nascimento; Henryk A Domanski; Johan Wejde; Otte Brosjö; Anders Rydholm; Margareth Isaksson; Nils Mandahl; Fredrik Mertens
The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma.
Genes, chromosomes & cancer 2004;40(3):218-28.
2004: Hildur Einarsdóttir; Magnus Karlsson; Johan Wejde; Henrik C F Bauer
Diffusion-weighted MRI of soft tissue tumours.
European radiology 2004;14(6):959-63.
2004: Anna Dahlén; Christopher D M Fletcher; Fredrik Mertens; Jonathan A Fletcher; Antonio R Perez-Atayde; M John Hicks; Maria Debiec-Rychter; Raf Sciot; Johan Wejde; Rikard Wedin; Nils Mandahl; Ioannis Panagopoulos
Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12).
The American journal of pathology 2004;164(5):1645-53.
2004: Wen-Hui Weng; Johan Wejde; Jan Ahlén; See-Tong Pang; Weng-Onn Lui; Catharina Larsson
Characterization of large chromosome markers in a malignant fibrous histiocytoma by spectral karyotyping, comparative genomic hybridization (CGH), and array CGH.
Cancer genetics and cytogenetics 2004;150(1):27-32.
2004: Maria Törnkvist; Johan Wejde; Jan Ahlén; Bertha Brodin; Olle Larsson
A novel case of synovial sarcoma of the kidney: impact of SS18/SSX analysis of renal hemangiopericytoma-like tumors.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2004;13(1):47-51.
2003: Anna Dahlén; Fredrik Mertens; Anders Rydholm; Otte Brosjö; Johan Wejde; Nils Mandahl; Ioannis Panagopoulos
Fusion, disruption, and expression of HMGA2 in bone and soft tissue chondromas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2003;16(11):1132-40.
2003: Clelia Tiziana Storlazzi; Fredrik Mertens; Antonio Nascimento; Margareth Isaksson; Johan Wejde; Otte Brosjo; Nils Mandahl; Ioannis Panagopoulos
Fusion of the FUS and BBF2H7 genes in low grade fibromyxoid sarcoma.
Human molecular genetics 2003;12(18):2349-58.
2001: M Hjertman; Johan Wejde; Olle Larsson
Characterization of hydrophobic prenyl groups of isoprenylated proteins in human cancer cells.
Biochemical and biophysical research communications 2001;288(3):736-41.
2001: W Lui; Johan Wejde; Edneia Tani; Otte Brosjö; Soili Kytölä; Catharina Larsson
A highly aggressive primitive mesenchymal tumor with a translocation (1;19)(q12;q13.2).
Cancer genetics and cytogenetics 2001;127(2):128-33.
2001: H Einarsdottir; Johan Wejde; Henrik C F Bauer
Pre-operative radiotherapy in soft tissue tumors. Assessment of response by static post-contrast MR imaging compared to histopathology.
Acta radiologica (Stockholm, Sweden : 1987) 2001;42(1):1-5.
2000: Leonard Girnita; Ada Girnita; Bertha Brodin; Yuntao Xie; Gunnar Nilsson; Anica Dricu; J Lundeberg; Johan Wejde; Armando Bartolazzi; K G Wiman; Olle Larsson
Increased expression of insulin-like growth factor I receptor in malignant cells expressing aberrant p53: functional impact.
Cancer research 2000;60(18):5278-83.
2000: L Kanter-Lewensohn; Leonard Girnita; Ada Girnita; Anica Dricu; G Olsson; L Leech; Gunnar Nilsson; A Hilding; Johan Wejde; Kerstin Brismar; Olle Larsson
Tamoxifen-induced cell death in malignant melanoma cells: possible involvement of the insulin-like growth factor-1 (IGF-1) pathway.
Molecular and cellular endocrinology 2000;165(1-2):131-7.
2000: Leonard Girnita; M Wang; Y Xie; Gunnar Nilsson; Anica Dricu; Johan Wejde; Olle Larsson
Inhibition of N-linked glycosylation down-regulates insulin-like growth factor-1 receptor at the cell surface and kills Ewing's sarcoma cells: therapeutic implications.
Anti-cancer drug design 2000;15(1):67-72.
2000: L Kanter-Lewensohn; Anica Dricu; Leonard Girnita; Johan Wejde; Olle Larsson
Expression of insulin-like growth factor-1 receptor (IGF-1R) and p27Kip1 in melanocytic tumors: a potential regulatory role of IGF-1 pathway in distribution of p27Kip1 between different cyclins.
Growth factors (Chur, Switzerland) 2000;17(3):193-202.
1999: Anica Dricu; Lena Kanter; M Wang; Gunnar Nilsson; M Hjertman; Johan Wejde; Olle Larsson
Expression of the insulin-like growth factor 1 receptor (IGF-1R) in breast cancer cells: evidence for a regulatory role of dolichyl phosphate in the transition from an intracellular to an extracellular IGF-1 pathway.
Glycobiology 1999;9(6):571-9.
1999: M Wang; Yuntao Xie; Leonard Girnita; Gunnar Nilsson; Anica Dricu; Johan Wejde; Olle Larsson
Regulatory role of mevalonate and N-linked glycosylation in proliferation and expression of the EWS/FLI-1 fusion protein in Ewing's sarcoma cells.
Experimental cell research 1999;246(1):38-46.
1999: Gunnar Nilsson; M Wang; Johan Wejde; Andris Kreicbergs; Olle Larsson
Detection of EWS/FLI-1 by Immunostaining. An Adjunctive Tool in Diagnosis of Ewing's Sarcoma and Primitive Neuroectodermal Tumour on Cytological Samples and Paraffin-Embedded Archival Material.
Sarcoma 1999;3(1):25-32.
1998: Johan Wejde; M Hjertman; M Carlberg; B Egestad; W J Griffiths; Jan Sjövall; Olle Larsson
Dolichol-like lipids with stimulatory effect on DNA synthesis: substrates for protein dolichylation?
Journal of cellular biochemistry 1998;71(4):502-14.
1998: Gunnar Nilsson; M Wang; Johan Wejde; Lena Kanter; J Karlén; E Tani; Andris Kreicbergs; Olle Larsson
Reverse transcriptase polymerase chain reaction on fine needle aspirates for rapid detection of translocations in synovial sarcoma.
Acta cytologica 1998;42(6):1317-24.
1998: L Kanter-Lewensohn; Anica Dricu; M Wang; Johan Wejde; R Kiessling; Olle Larsson
Expression of the insulin-like growth factor-1 receptor and its anti-apoptotic effect in malignant melanoma: a potential therapeutic target.
Melanoma research 1998;8(5):389-97.
1998: M Wang; Gunnar Nilsson; M Carlberg; Anica Dricu; Johan Wejde; Andris Kreicbergs; Olle Larsson
Specific and sensitive detection of the EWS/FLI1 fusion protein in Ewing's sarcoma by Western blotting.
Virchows Archiv : an international journal of pathology 1998;432(2):131-4.
1997: M Hjertman; Johan Wejde; Anica Dricu; M Carlberg; W J Griffiths; Jan Sjövall; Olle Larsson
Evidence for protein dolichylation.
FEBS letters 1997;416(3):235-8.
1997: L Kanter-Lewensohn; M A Hedblad; Johan Wejde; Olle Larsson
Immunohistochemical markers for distinguishing Spitz nevi from malignant melanomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1997;10(9):917-20.
1997: Anica Dricu; M Wang; M Hjertman; M Malec; H Blegen; Johan Wejde; M Carlberg; Olle Larsson
Mevalonate-regulated mechanisms in cell growth control: role of dolichyl phosphate in expression of the insulin-like growth factor-1 receptor (IGF-1R) in comparison to Ras prenylation and expression of c-myc.
Glycobiology 1997;7(5):625-33.
1995: Lena Kanter; H Blegen; Johan Wejde; B Lagerlöf; Olle Larsson
Utility of a proliferation marker in distinguishing between benign naevocellular naevi and naevocellular naevus-like lesions with malignant properties.
Melanoma research 1995;5(5):345-50.
1994: M Carlberg; M Hjertman; Johan Wejde; Olle Larsson
Mevalonate is essential for growth activation of human fibroblasts: evidence for a critical role of protein glycosylation in the prereplicative period.
Experimental cell research 1994;212(2):359-66.
1993: P Zickert; Johan Wejde; S Skog; A Zetterberg; Olle Larsson
Growth-regulatory properties of G1 cells synchronized by centrifugal elutriation.
Experimental cell research 1993;207(1):115-21.
1993: Johan Wejde; M Carlberg; M Hjertman; Olle Larsson
Isoprenoid regulation of cell growth: identification of mevalonate-labelled compounds inducing DNA synthesis in human breast cancer cells depleted of serum and mevalonate.
Journal of cellular physiology 1993;155(3):539-48.
1993: Olle Larsson; H Blegen; Johan Wejde; A Zetterberg
A cell cycle study of human mammary epithelial cells.
Cell biology international 1993;17(6):565-71.
1992: Olle Larsson; Johan Wejde
Dolichol delays G1-arrest for one cell cycle in human fibroblasts subjected to depletion of serum or mevalonate.
Journal of cell science 1992;103 ( Pt 4)():1065-72.
1992: Johan Wejde; H Blegen; Olle Larsson
Requirement for mevalonate in the control of proliferation of human breast cancer cells.
Anticancer research 1992;12(2):317-24.
1989: Olle Larsson; C Barrios; C Latham; J Ruiz; A Zetterberg; P Zickert; Johan Wejde
Abolition of mevinolin-induced growth inhibition in human fibroblasts following transformation by simian virus 40.
Cancer research 1989;49(20):5605-10.